Clinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.

Simple item page
dc.contributor.authorAtalar, B.
dc.contributor.authorSahin, B.
dc.contributor.authorMustafayev, T. Zoto
dc.contributor.authorGungor, G.
dc.contributor.authorAydin, G.
dc.contributor.authorYapici, B.
dc.contributor.authorOzyar, E.
dc.date.accessioned2023-02-21T12:32:26Z
dc.date.available2023-02-21T12:32:26Z
dc.date.issued2018-01-01
dc.description.issue1
dc.description.issueAPR
dc.description.pagesS765
dc.description.volume127
dc.identifier.doi10.1016/S0167-8140(18)31712-2
dc.identifier.urihttps://hdl.handle.net/11443/1071
dc.identifier.urihttp://dx.doi.org/10.1016/S0167-8140(18)31712-2
dc.identifier.wosWOS:000438676100200
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofRADIOTHERAPY AND ONCOLOGY
dc.titleClinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10.1016S0167-8140(18)31712-2.pdf
Size:
582.46 KB
Format:
Adobe Portable Document Format
Download

Collections

WOS